CSL Behring LLC Sustainability Profile
CSL Behring LLC, a global leader in biopharmaceuticals, is headquartered in the United States and operates extensively across North America, Europe, and Asia-Pacific. Founded in 1904, the company has established itself in the industry by focusing on innovative therapies for rare and serious medical conditions, particularly in immunology, haematology, and respiratory care. CSL Behring is renowned for its core products, including immunoglobulins and clotting factor therapies, which are distinguished by their high quality and efficacy. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its position as a trusted provider in the biopharmaceutical market. With a strong emphasis on patient-centric solutions, CSL Behring continues to achieve notable milestones, enhancing the lives of patients worldwide.
DitchCarbon Score
How does CSL Behring LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CSL Behring LLC's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CSL Behring LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of CSL Limited, which influences its climate commitments and emissions reporting. CSL Limited, the parent organisation, has set various climate initiatives that cascade down to CSL Behring. However, specific reduction targets or achievements for CSL Behring are not detailed in the available data. The company is part of broader sustainability efforts, including participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from CSL Limited. While CSL Behring LLC has not disclosed its own emissions figures, it is aligned with the climate strategies of its parent company, which aims to address carbon emissions comprehensively across its operations. The absence of specific emissions data highlights the need for ongoing transparency and commitment to climate action within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 250,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 58,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is CSL Behring LLC's Industry?
How Carbon Intensive is CSL Behring LLC's Location?
CSL Behring LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CSL Behring LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
